Cost-effectiveness of pertuzumab combined with trastuzumab and docetaxel as a first-line treatment for HER-2 positive metastatic breast cancer
Leung, Henry WC, Chan, Agnes LF, Muo, Chih-Hsin, Leung, John HangLanguage:
english
Journal:
Expert Review of Pharmacoeconomics & Outcomes Research
DOI:
10.1080/14737167.2018.1386559
Date:
October, 2017
File:
PDF, 1.22 MB
english, 2017